Align Technology, the global medical device company known for its pioneering Invisalign clear aligner system, has officially released its financial performance metrics for the third quarter of 2026. Reporting total revenues of $1.015 billion, the company demonstrated a resilient 1.9% year-over-year increase, signaling stability despite a complex macroeconomic landscape. This growth trajectory, while modest, is underpinned by a significant expansion in the company’s clear aligner segment, which remains the cornerstone of its business model.
Beyond the financial topline, the Q3 2026 report serves as a pivotal moment for the company, as it unveils a dual-track strategy: a major leadership transition and an aggressive push into new 3D-printing-based product categories. By leveraging its existing digital infrastructure—most notably the iTero scanner ecosystem—Align is positioning itself to capture new market share in protective dental equipment while simultaneously preparing for a change at the highest level of its corporate governance.
A New Chapter in Leadership: The Succession Plan
The most significant organizational news accompanying the financial results is the announcement of a planned leadership transition. Joseph M. Hogan, who has helmed the company as president and CEO since 2015, will step down from his executive duties at the end of 2026. His tenure has been marked by a period of intense innovation, international expansion, and the solidification of Align’s dominance in the orthodontic sector.
Taking the reins will be Jennifer L. Davis, an industry veteran who most recently served as CEO of Procter & Gamble’s Global Healthcare business. This appointment is widely viewed by market analysts as a strategic move to lean into the consumer-facing aspects of medical technology. Davis is scheduled to join the company as CEO-elect on November 2, 2026, working in tandem with Hogan to ensure a seamless transfer of responsibilities. This transition period is critical, as the company navigates the integration of new material platforms and the scaling of its direct-to-consumer and professional-facing product pipelines. Hogan will maintain his position on the Board of Directors until June 16, 2027, facilitating a period of continuity for stakeholders and employees alike.
Financial Performance and Operational Metrics
The third quarter results provide a granular look at the company’s shifting revenue streams. Clear aligner revenues, the primary driver of growth, reached $839.3 million, marking a 4.2% increase over the same period in 2025. This revenue growth was supported by a 6.6% year-over-year increase in case volumes, totaling 690,600 cases.
Conversely, the Imaging Systems and CAD/CAM services segment reported revenues of $175.5 million, reflecting a 7.6% decrease year-over-year. This decline suggests a cooling in the capital expenditure cycle for dental practices, which are often the purchasers of high-end scanner hardware. Despite this, the total number of global scanner units placed—encompassing leased, rented, and certified pre-owned systems—grew by double digits, surpassing 157,000 units. This indicates that while direct hardware sales may have slowed, the company’s digital footprint continues to expand, ensuring long-term dependency on the Align ecosystem.
Profitability metrics remained robust. The company reported a GAAP gross margin of 68.7% and a non-GAAP gross margin of 70.4%. Operating margins were 16.7% on a GAAP basis and 24.4% on a non-GAAP basis. Earnings per share (EPS) were also notable, with diluted net income per share reported at $1.90 GAAP and $2.80 non-GAAP, reflecting the company’s ongoing efforts to manage operational costs while investing in research and development.
Strategic Pivot: Innovation in 3D Printing
Align Technology is increasingly positioning itself as a leader in additive manufacturing. The report highlighted the rollout of the NXT Technology platform, a next-generation direct fabrication material system. This platform is designed to provide clinicians with unprecedented levels of control and precision in the design of dental appliances, moving the industry further away from traditional analog workflows and toward a fully digitized, custom-manufactured paradigm.
Perhaps the most innovative development in the Q3 report is the U.S. pilot of the Invisalign Sports Guard. By utilizing the company’s existing iTero scanning technology, Align can now produce custom-fitted, 3D-printed mouth guards for athletes. This development represents a calculated expansion into a market segment that traditionally relied on rudimentary boil-and-bite solutions or time-consuming custom-molded laboratory products.
The strategic logic behind this move is twofold. First, it addresses a growing awareness of concussion risks in contact sports, creating a high-value product category that complements the existing orthodontic business. Second, as Hogan noted, there is a significant demographic overlap between current Invisalign users—particularly in the "kids and teens" segment—and the youth sports market. By offering a high-performance sports guard, Align creates a new touchpoint that could serve as a gateway to broader orthodontic treatments, effectively turning sports medicine into a customer acquisition tool.
Market Analysis: Implications of Q3 2026
The Q3 2026 performance of Align Technology offers several key takeaways for investors and industry observers. First, the recovery in North American orthodontist shipments is a significant indicator of market health. After several quarters of decline, this reversal suggests that professional confidence is returning, and that the "post-pandemic" slump in discretionary dental spending may be bottoming out.
Second, the double-digit growth in Dental Service Organization (DSO) shipments across both general practitioners and orthodontists underscores the ongoing consolidation of the dental industry. Align’s ability to cater to these large-scale, high-volume entities remains a vital component of its business strategy.
However, the contraction in the Imaging Systems segment warrants careful observation. While the increase in the total installed base of scanners is positive for recurring revenue, the revenue drop in this segment suggests that the company must work harder to incentivize technology refreshes or justify the cost of new equipment to existing users.
The leadership transition also introduces a new variable. Jennifer L. Davis’s background in global healthcare, rather than strictly in dental manufacturing, suggests that Align may be looking to expand its footprint in the broader medical consumer space. Her success will likely be measured by how effectively she can integrate the company’s digital manufacturing capabilities into new, adjacent health categories while maintaining the loyalty of the orthodontic community.
Conclusion and Future Outlook
As Align Technology closes out the third quarter of 2026, the company finds itself at a crossroads. The transition from a company defined primarily by its aligner products to one that serves as a broad-spectrum digital dental manufacturer is well underway. The combination of strong clear aligner volumes, a massive digital footprint of 157,000+ scanners, and the promise of new 3D-printed innovations like the Invisalign Sports Guard provides a solid foundation for the incoming CEO.
While the decrease in imaging systems revenue highlights the challenges of maintaining growth in hardware sales, the core of the business remains remarkably resilient. By fostering a culture of continuous technological advancement and pivoting toward high-growth, high-awareness segments like athletic protection, Align is attempting to insulate itself from market volatility. As the company moves toward the end of 2026, the focus for stakeholders will remain on the efficacy of the leadership transition and the ability of the company to scale its new 3D-printing initiatives into profitable, large-scale product lines. The stage is set for a transformation that could redefine the role of digital manufacturing in modern dentistry for the next decade.
